If pancreatitis is suspected, Wegovy should be discontinued and appropriate diagnostic tests performed urgently Gallbladder problems : Rapid weight loss increases risk of gallstone formation, with cholelithiasis reported in approximately 1.6% of Wegovy users Intestinal obstruction/ileus : Cases have been reported in post-marketing surveillance, particularly in patients with pre-existing GI conditions Management strategies recommended by healthcare professionals include: Eating smaller, more frequent meals rather than large portions Avoiding high-fat, spicy, or heavily processed foods Staying well-hydrated, particularly if experiencing diarrhoea or vomiting, to prevent dehydration and potential acute kidney injury Not lying down immediately after eating to minimise reflux Ensuring adequate fibre intake to prevent constipation Taking the medication on the same day each week to maintain steady levels Most GI side effects improve over time as the body adjusts to the medication, typically becoming less troublesome after 4-8 weeks at each dose level
Infection with Hepatitis B virus (HBV) and Hepatitis C virus (HCV) is a known risk factor for HCC and the major contributor to the progression of chronic viral hepatitis to liver fibrosis/cirrhosis, ultimately leading to HCC ( Recently, there has been a growing focus on natural products as complementary and alternative medicine for both preventing and treating liver diseases (Xu et al., 2024)
Thus, reproductive senescence is a growing public health problem
But it also was intended to fuel research and development into new obesity treatments
No, a prior authorization confirms medical necessity but does not guarantee payment
